×
App Icon
The Standard e-Paper
Stay Informed, Even Offline
★★★★ - on Play Store
Read on the App

FDA approves RSV vaccine for moms-to-be to guard their newborns

US regulators on Aug 21, 2023 approved the first RSV vaccine for pregnant women so their babies will be born with protection against the respiratory infection. [AP Photo]

US regulators on Monday approved the first RSV vaccine for pregnant women so their babies will be born with protection against the respiratory infection.

RSV is notorious for filling hospitals with wheezing babies every fall and winter. The Food and Drug Administration cleared Pfizer's maternal vaccination to guard against a severe case of RSV when babies are most vulnerable - from birth through 6 months of age.

Get Full Access for Ksh299/Week
Uncover the stories others won’t tell. Subscribe now for exclusive access
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Already a subscriber? Log in